Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-09-04 5:13 pm Purchase | 2025-08-27 | 13G | Pliant Therapeutics, Inc. PLRX | Point72 Asset Management, L.P. | 4,085,017 6.700% | 4,085,017![]() (New Position) | Filing History |
2025-08-29 4:05 pm Purchase | 2025-08-28 | 13G | Wolverine World Wide, Inc. WWW | Point72 Asset Management, L.P. | 4,074,274 5.000% | 4,074,274![]() (New Position) | Filing History |
2025-08-28 4:05 pm Purchase | 2025-08-27 | 13G | Design Therapeutics, Inc. DSGN | Point72 Asset Management, L.P. | 2,942,719 5.200% | 2,942,719![]() (New Position) | Filing History |
2025-08-27 4:18 pm Purchase | 2025-08-26 | 13G | Invivyd, Inc. IVVD | Point72 Asset Management, L.P. | 16,730,467 8.000% | 16,730,467![]() (New Position) | Filing History |
2025-08-25 5:20 pm Purchase | 2025-08-22 | 13G | iBio, Inc. IBIO | Point72 Asset Management, L.P. | 14,289,118 9.900% | 14,289,118![]() (New Position) | Filing History |
2025-08-19 5:26 pm Purchase | 2025-08-15 | 13G | Kodiak Sciences Inc. KOD | Point72 Asset Management, L.P. | 2,908,836 5.500% | 2,908,836![]() (New Position) | Filing History |
2025-08-18 4:53 pm Purchase | 2025-08-15 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 4,327,952 5.000% | 2,020,128![]() (+87.53%) | Filing History |
2025-08-18 4:51 pm Purchase | 2025-08-11 | 13G | ALT5 Sigma Corporation ALTS | Point72 Asset Management, L.P. | 4,872,756 4.000% | 4,872,756![]() (New Position) | Filing History |
2025-08-14 5:39 pm Sale | 2025-06-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | Point72 Asset Management, L.P. | 2,307,824 2.700% | -1,970,023![]() (-46.05%) | Filing History |
2025-08-14 5:36 pm Sale | 2025-06-30 | 13G | VNET Group, Inc. VNET | Point72 Asset Management, L.P. | 38,180,856 2.400% | -40,644,666![]() (-51.56%) | Filing History |
2025-08-14 5:33 pm Sale | 2025-06-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Point72 Asset Management, L.P. | 1,445,825 4.500% | -448,479![]() (-23.68%) | Filing History |
2025-08-14 5:32 pm Sale | 2025-06-30 | 13G | Shoals Technologies Group, Inc. SHLS | Point72 Asset Management, L.P. | 0 0.000% | -9,026,464![]() (Position Closed) | Filing History |
2025-08-14 5:30 pm Sale | 2025-06-30 | 13G | CytomX Therapeutics, Inc. CTMX | Point72 Asset Management, L.P. | 8,084,623 5.100% | -5,009,777![]() (-38.26%) | Filing History |
2025-08-14 5:28 pm Purchase | 2025-06-30 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 1,527,930 7.600% | 528,516![]() (+52.88%) | Filing History |
2025-08-14 5:27 pm Sale | 2025-06-30 | 13G | Lumentum Holdings Inc. LITE | Point72 Asset Management, L.P. | 895,470 1.300% | -3,307,474![]() (-78.69%) | Filing History |
2025-08-14 5:25 pm Purchase | 2025-06-30 | 13G | Cybin Inc. CYBN | Point72 Asset Management, L.P. | 1,606,317 7.000% | 280,132![]() (+21.12%) | Filing History |
2025-08-14 5:23 pm Sale | 2025-06-30 | 13G | Regulus Therapeutics Inc. RGLS | Point72 Asset Management, L.P. | 241,157 0.300% | -3,682,649![]() (-93.85%) | Filing History |
2025-08-14 5:03 pm Sale | 2025-06-30 | 13G | Sagimet Biosciences Inc. SGMT | Point72 Asset Management, L.P. | 0 0.000% | -1,755,143![]() (Position Closed) | Filing History |
2025-08-14 5:01 pm Purchase | 2025-06-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Point72 Asset Management, L.P. | 1,531,038 7.300% | 318,310![]() (+26.25%) | Filing History |
2025-08-14 4:58 pm Purchase | 2025-06-30 | 13G | Ventyx Biosciences, Inc. VTYX | Point72 Asset Management, L.P. | 5,895,069 8.300% | 1,494,744![]() (+33.97%) | Filing History |